Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2001 Aug;85(4):568–575. doi: 10.1054/bjoc.2001.1949

Functional analysis of the mismatch repair system in bladder cancer

T Thykjaer 1, M Christensen 1, A B Clark 2, L R T Hansen 3, T A Kunkel 2, T F Ørntoft 1
PMCID: PMC2364098  PMID: 11506498

Abstract

In bladder cancer the observed microsatellite instability indicates that mismatch repair deficiency could be a frequently involved factor in bladder cancer progression. To investigate this hypothesis we analysed extracts of seven bladder cancer cell lines and, as a novel approach, five clinical cancer samples for mismatch repair activity. We found that one cell line (T24) and three of the clinical samples had a reduced repair capacity, measured to ~20% or less. The T24 cell extract was unable to repair a G-G mismatch and showed reduced repair of a 2-base loop, consistent with diminished function of the MSH2-MSH6 heterodimer. The functional assay was combined with measurement for mutation frequency, microsatellite analysis, sequencing, MTT assay, immunohistochemical analysis and RT-PCR analysis of the mismatch repair genes MSH2, MSH3, MSH6, PMS1, PMS2 and MLH1. A >7-fold relative increase in mutation frequency was observed for T24 compared to a bladder cancer cell line with a fully functional mismatch repair system. Neither microsatellite instability, loss of repair nor mismatch repair gene mutations were detected. However, RT-PCR analysis of mRNA levels did detect changes in the ratio of expression of the Mut S and Mut L homologues. The T24 cell line had the lowest MSH6 expression level of the cell lines tested. Identical RT-PCR analysis of seventeen clinical samples (normal urothelium, 7; pTa low stage, 5; and pT1-4 high stage, 5) indicated a significant change in the expression ratio between MSH3/MSH6 (P< 0.004), MSH2/MSH3 (P< 0.012) and PMS2/MLH1 P< 0.005, in high stage bladder tumours compared to normal urothelium and low stage tumours. Collectively, the data suggest that imbalanced expression of mismatch repair genes could lead to partial loss of mismatch repair activity that is associated with invasive bladder cancer. © 2001 Cancer Research Campaign http://www.bjcancer.com

Keywords: mismatch repair, bladder, microsatellite, MSH3, MSH6

Full Text

The Full Text of this article is available as a PDF (121.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aebi S., Fink D., Gordon R., Kim H. K., Zheng H., Fink J. L., Howell S. B. Resistance to cytotoxic drugs in DNA mismatch repair-deficient cells. Clin Cancer Res. 1997 Oct;3(10):1763–1767. [PubMed] [Google Scholar]
  2. Arzimanoglou I. I., Gilbert F., Barber H. R. Microsatellite instability in human solid tumors. Cancer. 1998 May 15;82(10):1808–1820. doi: 10.1002/(sici)1097-0142(19980515)82:10<1808::aid-cncr2>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  3. Baker S. J., Fearon E. R., Nigro J. M., Hamilton S. R., Preisinger A. C., Jessup J. M., vanTuinen P., Ledbetter D. H., Barker D. F., Nakamura Y. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science. 1989 Apr 14;244(4901):217–221. doi: 10.1126/science.2649981. [DOI] [PubMed] [Google Scholar]
  4. Bennett S. E., Umar A., Oshima J., Monnat R. J., Jr, Kunkel T. A. Mismatch repair in extracts of Werner syndrome cell lines. Cancer Res. 1997 Jul 15;57(14):2956–2960. [PubMed] [Google Scholar]
  5. Brewster S. F., Gingell J. C., Browne S., Brown K. W. Loss of heterozygosity on chromosome 18q is associated with muscle-invasive transitional cell carcinoma of the bladder. Br J Cancer. 1994 Oct;70(4):697–700. doi: 10.1038/bjc.1994.376. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Buermeyer A. B., Deschênes S. M., Baker S. M., Liskay R. M. Mammalian DNA mismatch repair. Annu Rev Genet. 1999;33:533–564. doi: 10.1146/annurev.genet.33.1.533. [DOI] [PubMed] [Google Scholar]
  7. Børresen A. L., Lothe R. A., Meling G. I., Lystad S., Morrison P., Lipford J., Kane M. F., Rognum T. O., Kolodner R. D. Somatic mutations in the hMSH2 gene in microsatellite unstable colorectal carcinomas. Hum Mol Genet. 1995 Nov;4(11):2065–2072. doi: 10.1093/hmg/4.11.2065. [DOI] [PubMed] [Google Scholar]
  8. Cairns P., Shaw M. E., Knowles M. A. Preliminary mapping of the deleted region of chromosome 9 in bladder cancer. Cancer Res. 1993 Mar 15;53(6):1230–1232. [PubMed] [Google Scholar]
  9. Christensen M., Jensen M. A., Wolf H., Orntoft T. F. Pronounced microsatellite instability in transitional cell carcinomas from young patients with bladder cancer. Int J Cancer. 1998 Aug 21;79(4):396–401. doi: 10.1002/(sici)1097-0215(19980821)79:4<396::aid-ijc15>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  10. Drummond J. T., Genschel J., Wolf E., Modrich P. DHFR/MSH3 amplification in methotrexate-resistant cells alters the hMutSalpha/hMutSbeta ratio and reduces the efficiency of base-base mismatch repair. Proc Natl Acad Sci U S A. 1997 Sep 16;94(19):10144–10149. doi: 10.1073/pnas.94.19.10144. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Drummond J. T., Li G. M., Longley M. J., Modrich P. Isolation of an hMSH2-p160 heterodimer that restores DNA mismatch repair to tumor cells. Science. 1995 Jun 30;268(5219):1909–1912. doi: 10.1126/science.7604264. [DOI] [PubMed] [Google Scholar]
  12. Fishel R., Lescoe M. K., Rao M. R., Copeland N. G., Jenkins N. A., Garber J., Kane M., Kolodner R. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell. 1993 Dec 3;75(5):1027–1038. doi: 10.1016/0092-8674(93)90546-3. [DOI] [PubMed] [Google Scholar]
  13. Genschel J., Littman S. J., Drummond J. T., Modrich P. Isolation of MutSbeta from human cells and comparison of the mismatch repair specificities of MutSbeta and MutSalpha. J Biol Chem. 1998 Jul 31;273(31):19895–19901. doi: 10.1074/jbc.273.31.19895. [DOI] [PubMed] [Google Scholar]
  14. Genuardi M., Anti M., Capozzi E., Leonardi F., Fornasarig M., Novella E., Bellacosa A., Valenti A., Gasbarrini G. B., Roncucci L. MLH1 and MSH2 constitutional mutations in colorectal cancer families not meeting the standard criteria for hereditary nonpolyposis colorectal cancer. Int J Cancer. 1998 Mar 16;75(6):835–839. doi: 10.1002/(sici)1097-0215(19980316)75:6<835::aid-ijc4>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  15. Ghimenti C., Tannergård P., Wahlberg S., Liu T., Giulianotti P. G., Mosca F., Fornaciari G., Bevilacqua G., Lindblom A., Caligo M. A. Microsatellite instability and mismatch repair gene inactivation in sporadic pancreatic and colon tumours. Br J Cancer. 1999 Apr;80(1-2):11–16. doi: 10.1038/sj.bjc.6690314. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Gonzalez-Zulueta M., Ruppert J. M., Tokino K., Tsai Y. C., Spruck C. H., 3rd, Miyao N., Nichols P. W., Hermann G. G., Horn T., Steven K. Microsatellite instability in bladder cancer. Cancer Res. 1993 Dec 1;53(23):5620–5623. [PubMed] [Google Scholar]
  17. Gu L., Hong Y., McCulloch S., Watanabe H., Li G. M. ATP-dependent interaction of human mismatch repair proteins and dual role of PCNA in mismatch repair. Nucleic Acids Res. 1998 Mar 1;26(5):1173–1178. doi: 10.1093/nar/26.5.1173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Habraken Y., Sung P., Prakash L., Prakash S. ATP-dependent assembly of a ternary complex consisting of a DNA mismatch and the yeast MSH2-MSH6 and MLH1-PMS1 protein complexes. J Biol Chem. 1998 Apr 17;273(16):9837–9841. doi: 10.1074/jbc.273.16.9837. [DOI] [PubMed] [Google Scholar]
  19. Kallioniemi A., Kallioniemi O. P., Citro G., Sauter G., DeVries S., Kerschmann R., Caroll P., Waldman F. Identification of gains and losses of DNA sequences in primary bladder cancer by comparative genomic hybridization. Genes Chromosomes Cancer. 1995 Mar;12(3):213–219. doi: 10.1002/gcc.2870120309. [DOI] [PubMed] [Google Scholar]
  20. Keen A. J., Knowles M. A. Definition of two regions of deletion on chromosome 9 in carcinoma of the bladder. Oncogene. 1994 Jul;9(7):2083–2088. [PubMed] [Google Scholar]
  21. Knowles M. A., Shaw M. E., Proctor A. J. Deletion mapping of chromosome 8 in cancers of the urinary bladder using restriction fragment length polymorphisms and microsatellite polymorphisms. Oncogene. 1993 May;8(5):1357–1364. [PubMed] [Google Scholar]
  22. Kolodner R. D., Marsischky G. T. Eukaryotic DNA mismatch repair. Curr Opin Genet Dev. 1999 Feb;9(1):89–96. doi: 10.1016/s0959-437x(99)80013-6. [DOI] [PubMed] [Google Scholar]
  23. Kyriazis A. A., Kyriazis A. P., McCombs W. B., 3rd, Peterson W. D., Jr Morphological, biological, and biochemical characteristics of human bladder transitional cell carcinomas grown in tissue culture and in nude mice. Cancer Res. 1984 Sep;44(9):3997–4005. [PubMed] [Google Scholar]
  24. Lettieri T., Marra G., Aquilina G., Bignami M., Crompton N. E., Palombo F., Jiricny J. Effect of hMSH6 cDNA expression on the phenotype of mismatch repair-deficient colon cancer cell line HCT15. Carcinogenesis. 1999 Mar;20(3):373–382. doi: 10.1093/carcin/20.3.373. [DOI] [PubMed] [Google Scholar]
  25. Li M., Zhang Z. F., Reuter V. E., Cordon-Cardo C. Chromosome 3 allelic losses and microsatellite alterations in transitional cell carcinoma of the urinary bladder. Am J Pathol. 1996 Jul;149(1):229–235. [PMC free article] [PubMed] [Google Scholar]
  26. Lothe R. A. Microsatellite instability in human solid tumors. Mol Med Today. 1997 Feb;3(2):61–68. doi: 10.1016/S1357-4310(96)10055-1. [DOI] [PubMed] [Google Scholar]
  27. Mahdy E., Yoshihiro S., Zech L., Wester K., Pan Y., Busch C., Döhner H., Kallioniemi O., Bergerheim U., Malmström P. U. Comparison of comparative genomic hybridization, fluorescence in situ hybridization and flow cytometry in urinary bladder cancer. Anticancer Res. 1999 Jan-Feb;19(1A):7–12. [PubMed] [Google Scholar]
  28. Marra G., Iaccarino I., Lettieri T., Roscilli G., Delmastro P., Jiricny J. Mismatch repair deficiency associated with overexpression of the MSH3 gene. Proc Natl Acad Sci U S A. 1998 Jul 21;95(15):8568–8573. doi: 10.1073/pnas.95.15.8568. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Miyamoto H., Shuin T., Torigoe S., Iwasaki Y., Kubota Y. Retinoblastoma gene mutations in primary human bladder cancer. Br J Cancer. 1995 Apr;71(4):831–835. doi: 10.1038/bjc.1995.160. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. O'Toole C., Price Z. H., Ohnuki Y., Unsgaard B. Ultrastructure, karyology and immunology of a cell line originated from a human transitional-cell carcinoma. Br J Cancer. 1978 Jul;38(1):64–76. doi: 10.1038/bjc.1978.164. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Orlow I., Lianes P., Lacombe L., Dalbagni G., Reuter V. E., Cordon-Cardo C. Chromosome 9 allelic losses and microsatellite alterations in human bladder tumors. Cancer Res. 1994 Jun 1;54(11):2848–2851. [PubMed] [Google Scholar]
  32. Orntoft T. F., Meldgaard P., Pedersen B., Wolf H. The blood group ABO gene transcript is down-regulated in human bladder tumors and growth-stimulated urothelial cell lines. Cancer Res. 1996 Mar 1;56(5):1031–1036. [PubMed] [Google Scholar]
  33. Polascik T. J., Cairns P., Chang W. Y., Schoenberg M. P., Sidransky D. Distinct regions of allelic loss on chromosome 4 in human primary bladder carcinoma. Cancer Res. 1995 Nov 15;55(22):5396–5399. [PubMed] [Google Scholar]
  34. Presti J. C., Jr, Reuter V. E., Galan T., Fair W. R., Cordon-Cardo C. Molecular genetic alterations in superficial and locally advanced human bladder cancer. Cancer Res. 1991 Oct 1;51(19):5405–5409. [PubMed] [Google Scholar]
  35. Rasheed S., Gardner M. B., Rongey R. W., Nelson-Rees W. A., Arnstein P. Human bladder carcinoma: characterization of two new tumor cell lines and search for tumor viruses. J Natl Cancer Inst. 1977 Apr;58(4):881–890. doi: 10.1093/jnci/58.4.881. [DOI] [PubMed] [Google Scholar]
  36. Rigby C. C., Franks L. M. A human tissue culture cell line from a transitional cell tumour of the urinary bladder: growth, chromosone pattern and ultrastructure. Br J Cancer. 1970 Dec;24(4):746–754. doi: 10.1038/bjc.1970.89. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Ruppert J. M., Tokino K., Sidransky D. Evidence for two bladder cancer suppressor loci on human chromosome 9. Cancer Res. 1993 Nov 1;53(21):5093–5095. [PubMed] [Google Scholar]
  38. Shcherbakova P. V., Kunkel T. A. Mutator phenotypes conferred by MLH1 overexpression and by heterozygosity for mlh1 mutations. Mol Cell Biol. 1999 Apr;19(4):3177–3183. doi: 10.1128/mcb.19.4.3177. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Simon R., Bürger H., Brinkschmidt C., Böcker W., Hertle L., Terpe H. J. Chromosomal aberrations associated with invasion in papillary superficial bladder cancer. J Pathol. 1998 Aug;185(4):345–351. doi: 10.1002/(SICI)1096-9896(199808)185:4<345::AID-PATH109>3.0.CO;2-0. [DOI] [PubMed] [Google Scholar]
  40. Taylor J. A., Li Y., He M., Mason T., Mettlin C., Vogler W. J., Maygarden S., Liu E. p53 mutations in bladder tumors from arylamine-exposed workers. Cancer Res. 1996 Jan 15;56(2):294–298. [PubMed] [Google Scholar]
  41. Toyota M., Ahuja N., Ohe-Toyota M., Herman J. G., Baylin S. B., Issa J. P. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A. 1999 Jul 20;96(15):8681–8686. doi: 10.1073/pnas.96.15.8681. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Umar A., Boyer J. C., Kunkel T. A. DNA loop repair by human cell extracts. Science. 1994 Nov 4;266(5186):814–816. doi: 10.1126/science.7973637. [DOI] [PubMed] [Google Scholar]
  43. Umar A., Koi M., Risinger J. I., Glaab W. E., Tindall K. R., Kolodner R. D., Boland C. R., Barrett J. C., Kunkel T. A. Correction of hypermutability, N-methyl-N'-nitro-N-nitrosoguanidine resistance, and defective DNA mismatch repair by introducing chromosome 2 into human tumor cells with mutations in MSH2 and MSH6. Cancer Res. 1997 Sep 15;57(18):3949–3955. [PubMed] [Google Scholar]
  44. Umar A., Risinger J. I., Glaab W. E., Tindall K. R., Barrett J. C., Kunkel T. A. Functional overlap in mismatch repair by human MSH3 and MSH6. Genetics. 1998 Apr;148(4):1637–1646. doi: 10.1093/genetics/148.4.1637. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Voorter C., Joos S., Bringuier P. P., Vallinga M., Poddighe P., Schalken J., du Manoir S., Ramaekers F., Lichter P., Hopman A. Detection of chromosomal imbalances in transitional cell carcinoma of the bladder by comparative genomic hybridization. Am J Pathol. 1995 Jun;146(6):1341–1354. [PMC free article] [PubMed] [Google Scholar]
  46. Wang T. F., Kleckner N., Hunter N. Functional specificity of MutL homologs in yeast: evidence for three Mlh1-based heterocomplexes with distinct roles during meiosis in recombination and mismatch correction. Proc Natl Acad Sci U S A. 1999 Nov 23;96(24):13914–13919. doi: 10.1073/pnas.96.24.13914. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Wingo P. A., Ries L. A., Giovino G. A., Miller D. S., Rosenberg H. M., Shopland D. R., Thun M. J., Edwards B. K. Annual report to the nation on the status of cancer, 1973-1996, with a special section on lung cancer and tobacco smoking. J Natl Cancer Inst. 1999 Apr 21;91(8):675–690. doi: 10.1093/jnci/91.8.675. [DOI] [PubMed] [Google Scholar]
  48. Yu Z., Chen J., Ford B. N., Brackley M. E., Glickman B. W. Human DNA repair systems: an overview. Environ Mol Mutagen. 1999;33(1):3–20. doi: 10.1002/(sici)1098-2280(1999)33:1<3::aid-em2>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES